“…Positive results in either model suggest that the test compound, or its metabolite crossed the blood–brain barrier and exerted its effect in the central nervous system [ 1 ]. In this review, all experiments consisted initially of phenotypic screens in rodents using predominantly PTZ [ 6 , 13 , 18 , 19 , 21 , 22 , 24 , 25 , 27 , 28 ], MES [ 20 , 22 , 24 ] and pilocarpine [ 16 , 23 , 26 , 32 ] seizure models. A few researchers dared to test their extracts in more than one phenotypic screening models [ 13 , 20 , 22 , 24 ].…”